Active Ingredient: BRIMONIDINE TARTRATE; TIMOLOL MALEATE
Proprietary Name: BRIMONIDINE TARTRATE AND TIMOLOL MALEATE
Dosage Form; Route of Administration: SOLUTION/DROPS; OPHTHALMIC
Strength: 0.2%;EQ 0.5% BASE
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A091086
Product Number: 001
Approval Date: Oct 31, 2022
Applicant Holder Full Name: SENTISS AG
Marketing Status:
Prescription
Patent and Exclusivity Information